Stoke Therapeutics, Inc. (STOK) Insider Trading -- Recent Executive & Director Transactions

12 insiders reported 148 Form 4 transactions for Stoke Therapeutics, Inc. (STOK) over the past 18 months (most recent 2026-08-18). Recent activity: Kaye Edward M. MD (Director) Buy 26,250 shares, Ticho Barry (CHIEF MEDICAL OFFICER) Buy 10,000 shares, Allan Jonathan (GENERAL COUNSEL & CORP SEC) Buy 6,000 shares, Kaye Edward M. MD (Director) Sell 11,930 shares, Ticho Barry (CHIEF MEDICAL OFFICER) Sell 4,525 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-18Kaye Edward M. MDDirectorBuy26,250$0
2026-08-18Ticho BarryCHIEF MEDICAL OFFICERBuy10,000$0
2026-08-18Allan JonathanGENERAL COUNSEL & CORP SECBuy6,000$0
2026-08-18Kaye Edward M. MDDirectorSell11,930$381,846
2026-08-18Ticho BarryCHIEF MEDICAL OFFICERSell4,525$144,833
2026-08-18Allan JonathanGENERAL COUNSEL & CORP SECSell2,716$86,932
2026-08-18Kaye Edward M. MDDirectorSell637$20,682
2026-08-18Ticho BarryCHIEF MEDICAL OFFICERSell242$7,857
2026-08-18Allan JonathanGENERAL COUNSEL & CORP SECSell145$4,708
2026-08-05Ticho BarryCHIEF MEDICAL OFFICERSell5,907$171,008
2026-08-05Ticho BarryCHIEF MEDICAL OFFICERSell1,269$37,377
2026-07-06Ticho BarryCHIEF MEDICAL OFFICERSell6,728$219,434
2026-07-06Ticho BarryCHIEF MEDICAL OFFICERSell500$16,634
2026-06-18Allan JonathanGENERAL COUNSEL & CORP SECSell1,457$43,637
2026-06-03Ticho BarryCHIEF MEDICAL OFFICERSell1,795$54,891
2026-05-05Ticho BarryCHIEF MEDICAL OFFICERSell2,243$73,548
2026-04-03Ticho BarryCHIEF MEDICAL OFFICERSell1,838$60,029
2026-03-24Allan JonathanGENERAL COUNSEL & CORP SECSell8,692$292,399
2026-03-24Allan JonathanGENERAL COUNSEL & CORP SECSell601$20,680
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERBuy1,365$2,989
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell3,577$117,111
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell2,587$86,354
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell6,100$190,808
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell483$15,355
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell103$3,384

Source: SEC Form 4 filings · as of 2026-08-18